Lincoln National Corp Abb Vie Inc. Transaction History

Lincoln National Corp

$3.11 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $509,985 - $581,081	3,191 Added 3.97%	83,505 $15.2 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $461,510 - $519,769	3,354 Added 4.36%	80,314 $12.4 Million
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $226,034 - $261,667	1,692 Added 2.25%	76,960 $11.5 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $293,509 - $365,253	2,215 Added 3.03%	75,268 $10.1 Million
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $709,601 - $817,211	4,907 Added 7.2%	73,053 $11.6 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $259,054 - $310,674	1,873 Added 2.83%	68,146 $11 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $1.2 Million - $1.38 Million	8,937 Added 15.59%	66,273 $8.89 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $433,090 - $550,599	-3,147 Reduced 5.2%	57,336 $8.78 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $71,533 - $88,752	-542 Reduced 0.89%	60,483 $9.81 Million
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $270,293 - $341,999	2,516 Added 4.3%	61,025 $8.26 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $268,979 - $305,331	2,528 Added 4.52%	58,509 $6.31 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $309,633 - $344,949	2,943 Added 5.55%	55,981 $6.31 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $610,219 - $671,778	5,965 Added 12.67%	53,038 $5.74 Million
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $414,121 - $559,107	5,145 Added 12.27%	47,073 $5.04 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $124,913 - $146,606	1,454 Added 3.59%	41,928 $3.67 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $376,021 - $503,172	5,125 Added 14.5%	40,474 $3.97 Million
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $297,216 - $450,616	-4,608 Reduced 11.53%	35,349 $2.69 Million
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $448,648 - $561,355	6,220 Added 18.44%	39,957 $3.54 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $316,789 - $380,871	5,030 Added 17.52%	33,737 $2.56 Million
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $385,199 - $492,374	5,863 Added 25.67%	28,707 $2.09 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $158,522 - $186,573	2,055 Added 9.89%	22,844 $1.84 Million
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $141,609 - $174,642	1,819 Added 9.59%	20,789 $1.92 Million
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $629,393 - $699,688	-7,079 Reduced 27.18%	18,970 $1.79 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $72,003 - $85,196	-802 Reduced 2.99%	26,049 $2.41 Million
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $1.22 Million - $1.64 Million	-13,298 Reduced 33.12%	26,851 $2.54 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $1.77 Million - $1.94 Million	19,763 Added 96.94%	40,149 $3.88 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $31,222 - $39,881	447 Added 2.24%	20,386 $1.81 Million
Q2 2017 Aug 07, 2017	BUY	N/A	19,939	19,939 $1.45 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Account